Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:00:22.644Z.
Calculation as of: 2026-10-06T19:00:22.644Z.
Quote observation: 2026-10-06T18:59:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d554412806125b06490580232e6d80b3120c6a72214b764814008bb1d876b03
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Ainos, Inc.
Market Cap
$9.70M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Ainos, Inc. (AIMD) | $9.70M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.70M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.82M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.90M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.22M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.15M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.41M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.42M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
